Oscar Health

Oscar Health, Inc. operates as a health insurance company which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Oscar Health reports robust growth and profitability outlook for 2023

Oscar Health's 2022 performance showcased strong growth in membership, improved financial ratios, and a focus on efficiency and profitability in the insurance business.
The company's strengths lie in exceeding targets for capital, stable premiums, and leveraging investment income for competitive advantage.
Challenges include financial transparency and managing risk pool dynamics, while opportunities exist in market expansion, PBM contract benefits, and margin expansion strategies.
Overall, Oscar Health's strategic focus on growth, efficiency, and profitability positions it well for future success in the insurance market.

Oscar Health achieves Q1 profitability, focuses on tech innovation

Oscar Health's Q1 2023 earnings call highlighted strong financial performance, operational efficiency, and a strategic focus on profitability priorities.
While facing challenges such as reshaping strategies and market-specific dynamics, the company is well-positioned to leverage opportunities for growth and innovation.
With a mission-driven approach, a growing member base, and a commitment to enhancing technology, Oscar Health aims to sustain profitability and market competitiveness.

Oscar Health reports strong Q2 earnings, eyes growth opportunities

Oscar Health's Q2 performance reflects positive trends in profitability, membership growth, and strategic planning for future expansion.
While facing challenges in pricing strategies and achieving profitability targets, the company is well-positioned to capitalize on growth opportunities.
With a focus on innovation, customer satisfaction, and market expansion, Oscar Health aims to strengthen its competitive position in the healthcare industry.

Oscar Health excels in Q3, eyes profitability in 2024

Oscar Health's Q3 2023 earnings call highlighted strong performance metrics, a focus on profitability in 2024, and strategic initiatives to drive growth and enhance member satisfaction. While facing challenges in narrowing EBITDA losses, the company remains optimistic about its trajectory and expressed confidence in its strategic direction and employee dedication.

Oscar Health achieves insurance profitability, eyes growth amid market changes

Oscar Health's Q4 2023 Earnings Call highlighted achievements in insurance company profitability and significant improvements in total company adjusted EBITDA.
The company is well-positioned for profitability in 2024, focusing on serving over 1.3 million members with new products and technology enhancements.
Challenges include navigating potential market dynamics changes due to ACA subsidy adjustments, but Oscar Health is proactively addressing these concerns.

Oscar Health posts record revenue and profitability, eyes market expansion

Oscar Health delivered robust Q1 results, showcasing strong revenue growth, improved profitability, and strategic market expansion initiatives.
Despite facing challenges in achieving total company adjusted EBITDA profitability, the company's financial stability and growth prospects remain promising.
With a focus on operational efficiency and long-term strategic vision, Oscar Health is well-positioned to capitalize on market opportunities and drive sustained growth.

Oscar Health reports strong Q2 results, eyes growth through technology

Oscar Health's Q2 2024 earnings call showcased robust financial performance, driven by revenue growth and improved EBITDA. The company's membership expansion and strategic focus on technology-driven engagement are key strengths. Challenges include policy uncertainties and meeting raised guidance, while opportunities exist in market resonance and technological advancements.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Harvard Business School classmates Josh Kushner, Mario Schlosser, and Kevin Nazemi decide to start a company to demystify health insurance.

Oscar, named after Kushner's great grandfather, raises $51.5 million through Series A, AA, and AAA funding from Gary Vaynerchuk, Dave Gilboa, Khosla Ventures, Lerer Ventures, General Catalyst Thrive Capital, Founders Fund, Kal Vepuri, BoxGroup and more, with a pre-money valuation of $70 million.

Series A4 funding drops a nice $30 million from investors into Oscar's wallet, bumping its valuation to $310 million.

Oscar secures $80 million in Series A5 funding, mostly from Formation 8. Pre-money valuation reaches $500 million.

Nearly 150,000 members call themselves Oscar-insured across four states alone (NY, NJ, CA, & TX).

Oscar's member services team sets up camp in Tempe, Ariz.

Mount Sinai Health System partners to open the Oscar Center, offering primary care, mental health, and wellness services to members—sort of like a fancy urgent care. 😎

Oscar offers coverage to New York small businesses for their employees. 

The Cleveland Clinic collab drops in the Midwest market to cover individuals across northeastern Ohio. 

Oscar expands to new regions, including Tennessee, Ohio, Texas, New Jersey, and California.

Hey, y’all: A partnership with Humana helps Oscar cover small businesses up to 50 employees in Nashville, Tenn.

Series G round nets Oscar $165 million in funding, zooming the estimated value to a whopping $3.2 billion.

Alphabet (parent company to Google) decides to invest, cutting Oscar a check for $375 million.

The "Cigna + Oscar" collab brings together Cigna's vast network to Oscar's member-focused experience for small businesses. 

Gary Vaynerchuk and Khosla Ventures go for round 2, but this time, a sweet $225 million with the help of Builders VC.

Tiger Global Management invests $140 million in Oscar, as the company's member count exceeds 400,000.

Oscar begins trading on the New York Stock Exchange under the ticker $OSCR.

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, today announced its financial results for the fourth quarter and full year ended December 31, 2023. “Oscar reported strong 2023 results with most core metrics exceeding our expectations for the full year. We delivered on our commitment for Insurance Company Adjusted EBITDA profitability and have a clear line of sight into consolidated Adjusted EBITDA profitability in 2.

Oscar Health Announces Strong Results for Fourth Quarter and Full Year 2023; Introduces Full Year 2024 Outlook Including Total Company Adjusted EBITDA Profitability

Arch Capital

Universal Insurance Hlds

Looking for the best insurance stocks to buy in January 2024? Some say that “risk happens slowly, then all at once.

The 3 Best Insurance Stocks to Buy Now: January 2024

Oscar Health offers an innovative healthcare insurance platform using AI and big data to match plans to individual situations, producing high patient satisfaction. Membership growth has stalled due to portfolio sculpting efforts but is likely to resume. The company plans to expand in existing markets and introduce new programs, leveraging its existing network of providers.

Oscar Health: Flexible Business Model Is Paying Off

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, announced that on January 22, 2024 the Compensation Committee of Oscar's Board of Directors approved the grant of employment inducement restricted stock unit awards covering an aggregate of 104,586 Class A shares of Oscar's common stock to 11 new non-executive employees of Oscar and its affiliates, to induce them to join Oscar and its affiliates. The awards generally vest quarterly ove.

Oscar Health, Inc. Announces Inducement Grants under Section 303A.08 of the NYSE Listed Company Manual

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, will release its fourth quarter and full year 2023 financial results after the market closes on Wednesday, February 7, 2024. Management will review these results in a conference call beginning at 5:00 PM (ET). The call-in number and webcast link are as follows: Live Call: (877) 400-4403 Conference ID: 6577079 Webcast Link The call will be archived and available on Oscar's investor rela.

Oscar Health, Inc. 2023 Fourth Quarter and Full Year Earnings Conference Call

Oscar Health, Inc. (OSCR) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Oscar Health, Inc. (OSCR) Is Attractively Priced Despite Fast-paced Momentum

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, today announced that Chief Executive Officer, Mark Bertolini, is scheduled to present and provide a business update at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024 at approximately 9:00 AM PT (12:00 PM ET) in San Francisco, CA. All interested parties are invited to listen to a live webcast of the presentation by visiting www.ir.hioscar.com and select.

Oscar Health, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference

AppLovin Corp

Fiverr

Among thousands of investment opportunities, identifying stocks with the potential to turn a modest investment into a substantial fortune becomes a compelling pursuit. In finance, three stock picks stand out prominently as strong contenders.

Building Wealth: Top 3 Stocks to Turn $500 into a Small Fortune

Oscar Health, Inc. (OSCR) Shows Fast-paced Momentum But Is Still a Bargain Stock

Landsea Homes

Rocky Brands

Udemy

November marked an exceptional month for stocks. Interest rate-sensitive sectors and stocks like Udemy (UDMY), Oscar Health (OSCR), Rocky Brands (RCKY) and Landsea Homes (LSEA) outperformed in the month.

November Marks Best Month Since 2022: 4 Best Sectors & Stock Picks

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, is announcing this year's recipients of its Culturally Competent Care (CCC) Grants. The initiative, which is a component of Oscar's CCC Program, delivers financial and on-the-ground support to select organizations who provide access to care in underserved communities. Aligned with our commitment to continue expanding offerings for both rural and Hispanic and Latino communities, Oscar i.

Oscar Health, Inc. Announces 2023 Culturally Competent Care Grant Recipients, Bolstering its Efforts to Support Rural and Hispanic and Latino Communities

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, today announced that an affiliate of Deerfield Management Company, L.P. (“Deerfield”) and the Anahata Foundation (“Anahata”), a charitable foundation established by Mark T. Bertolini, Oscar's Chief Executive Officer, each entered into a Stock Purchase Agreement for the purchase in private placement of shares of Oscar's Class A common stock (“Common Stock”) from a single selling shareho.

Oscar Health, Inc. Announces that Mark Bertolini's Foundation and Deerfield Management have Entered into an Agreement with a Selling Shareholder to Purchase Shares of Oscar Health

Consider buying Oscar Health before it achieves consistent positive earnings, as higher valuation will limit potential future gains. While yet to turn a profit, recent positive adjusted EBITDA and management focus on profitability and faster growth signal potential for positive net income in the next 1-2 years. Margin Improvement Focus: Oscar Health's strategy of pricing above peers, leveraging Medicaid redeterminations, and targeting lower Medical Loss Ratio, aims to boost margins.

Oscar Health, Inc.: On Path To Profitability Through Strategic Margins And Unique Technology

Does Oscar Health, Inc. (OSCR) have what it takes to be a top stock pick for momentum investors? Let's find out.

Oscar Health, Inc. (OSCR) is a Great Momentum Stock: Should You Buy?

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, today announced that Chief Executive Officer, Mark Bertolini, is scheduled to present and provide a business update at the 5th Annual Wolfe Research Healthcare Conference on Wednesday, November 15, 2023 at approximately 2:15 PM ET. All interested parties are invited to listen to a live webcast of the fireside chat by visiting www.ir.hioscar.com and selecting the “Events & Presentat.

Oscar Health, Inc. to Present at 5th Annual Wolfe Research Healthcare Conference

Oscar Health Inc. membership retention and more personalization were highlighted during the healthcare insurance provider's third-quarter earnings report released Tuesday (Nov. 7). The company, which provides individuals insurance under the Affordable Care Act, said it expects to reach profitability in 2024 and updated its financial outlook for the remainder of this year.

Oscar Health Focuses on Member Experience and Technology-Driven Solutions for Growth

Oscar Health, Inc. (NYSE:OSCR ) Q3 2023 Earnings Conference Call November 7, 2023 8:30 AM ET Company Participants Chris Potochar - VP, Treasury & IR Mark Bertolini - CEO Scott Blackley - CFO Conference Call Participants Stephen Baxter - Wells Fargo Adam Ron - Bank of America Josh Raskin - Nephron Research Operator Good morning. My name is Rob, and I will be your conference operator today.

Oscar Health, Inc. (OSCR) Q3 2023 Earnings Call Transcript

Oscar Health reported a $65.7 million loss as the provider of individual coverage under the Affordable Care Act also known as Obamacare works its way to profitability under new management in part by raising rates.

Oscar Health's Losses Narrow As Insurer Looks To 2024 Profitability

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, today announced its financial results for the third quarter ended September 30, 2023. “Oscar reported strong third quarter results with significant year-over-year improvement across all core ratios,” said Mark Bertolini, CEO of Oscar. “We are pleased with our year-to-date outperformance and are raising our full year outlook for 2023 InsuranceCo Adjusted EBITDA and cons.

Oscar Health Announces Results for Third Quarter 2023 and Raises Full Year 2023 Adjusted EBITDA Outlook; New +Oscar Agreement

The mean of analysts' price targets for Oscar Health, Inc. (OSCR) points to a 59.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Wall Street Analysts Believe Oscar Health, Inc. (OSCR) Could Rally 59.34%: Here's is How to Trade

ACV Auctions

Affirm

ImmunoGen

Electrameccanica

OSCR, IMGN, AFRM, ACVA and SOLO have been added to the Zacks Rank #1 (Strong Buy) List on October 20, 2023.

New Strong Buy Stocks for October 20th

Oscar Health Inc. OSCR, -3.76% said Thursday it plans to expand into 165 new markets in 13 states in 2024, through its individual and family health insurance plans. The New York-based company said the expansion will bring it to 18 states and 512 counties, growing its presence in Arizona, Florida, Georgia, Illinois, Iowa, Kansas, Missouri, North Carolina, Ohio, Oklahoma, Tennessee, Texas, and Virginia.

Oscar Health announces expansion plans for 2024 and stock pops 6%

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, today announced its 2024 market expansion efforts for its Individual and Family Plans, marking Oscar's eleventh consecutive year as a prominent carrier in the ACA marketplace. Oscar will offer its innovative, member-centric plans in 165 new counties, making high-quality and affordable healthcare a reality for more consumers. Starting in 2024, Oscar will have a footprint in 18 states an.

Oscar Health, Inc. Announces 2024 Market Expansion Plans, Offering Affordable, Accessible, and Technology-Enabled Care for the Eleventh Consecutive Year

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, will release its third quarter 2023 financial results before the market opens on Tuesday, November 7, 2023. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: (877) 400-4403 Conference ID: 6577079 Webcast Link The call will be archived and available on O.

Oscar Health, Inc. 2023 Third Quarter Conference Call

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built around a full stack technology platform, today announced the appointment of two seasoned healthcare executives to round out its leadership bench and further propel its vision to refactor healthcare. Kerry Sain has joined the company as the Executive Vice President of +Oscar, effective August 14, 2023, and Steven Kelmar will join as Executive Vice President and Chief of Staff to the CEO.

News for Oscar Health Stock (OSCR)